Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Most patients choose weekends as off-days, but the specific days do not matter as long as they are consistent
Stomach Pain on Reta vs Other GLP-1 Compounds Cross-trial comparisons have significant limitations, but directional data helps contextualize the stomach pain experience on retatrutide: Metric Retatrutide 12 mg Semaglutide 2.4 mg Tirzepatide 15 mg Overall GI events ~67% ~74% ~51% Nausea ~46% ~44% ~31% Diarrhea ~33% ~30% ~23% Vomiting ~22% ~24% ~12% Discontinuation due to GI AEs ~8% ~7% ~6% Key observation: Despite targeting three receptors instead of one or two, retatrutide's overall GI adverse event rate is comparable to semaglutide and modestly higher than tirzepatide
Real-world Evidence: There is mounting evidence that GLP-1 agonists administered for diabetes or obesity correspond to reduced addiction risk
Do the three components react with each other in the vial or in solution
Co-formulation of GLP-1 RA with an absorption enhancer is necessary to achieve adequate bioavailability after oral administration [11]
US$ 25.03
US$ 21.52
US$ 20.49
US$ 29.35
US$ 24.94
US$ 27.28
US$ 26.38
US$ 21.56
US$ 20.20
US$ 26.15
